Organ-Specific Production Control of Vascular Endothelial Growth Factor in Ovarian Hyperstimulation Syndrome-Model Rats

Endocrine Journal

Volumn 50, Issue 5, 2003, Pages 515-525

  Ishikawa, Katsuyasu ^a   Ohba, Takashi ^a   Tanaka, Nobuyuki ^a   Iqbal, Munir ^b   Okamura, Yoshinori ^a   Okamura, Hitoshi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HCG; OHSS; Ovary; Progesterone; Rat; VEGF

Indexed keywords

CHORIONIC GONADOTROPIN; MIFEPRISTONE; PROGESTERONE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HORMONE ACTION; HORMONE SYNTHESIS; INJECTION; LIVER; LUNG; NONHUMAN; ORGAN WEIGHT; OVARY; OVARY DISEASE; OVARY HYPERSTIMULATION; RAT; TISSUE; TISSUE DISTRIBUTION;

ANIMALS; ANIMALS, NEWBORN; CHORIONIC GONADOTROPIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENE EXPRESSION; HORMONE ANTAGONISTS; HORSES; HUMANS; MIFEPRISTONE; ORGAN SIZE; OVARIAN HYPERSTIMULATION SYNDROME; OVARY; PROGESTERONE; RATS; RATS, WISTAR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0344441417     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.50.515     Document Type: Article

References (48)

1. Schenker JG, Weinstein D (1978) Ovarian hyperstimulation syndrome: a current survey. Fertil Steril 30: 255-268.
2. Brinsden PR, Wada I, Tan SL, Balen A, Jacobs HS (1995) Diagnosis, prevention and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 102: 767-772.
3. Abramov Y, Barak V, Nisman B, Schenker JG (1997) Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril 67: 261-265.
4. Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309.
5. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985.
6. Levin ER, Rosen GF, Cassidenti DL, Yee B, Meldrum D, Wisot A, Pedram A (1998) Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome. J Clin Invest 102: 1978-1985.
7. Lee A, Burry KA, Christenson LK, Patton PE, Stouffer RL (1997) Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization. Fertil Steril 68: 305-311.
8. Chen CD, Wu MY, Chen HF, Chen SU, Ho HN, Yang YS (1999) Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome. Fertil Steril 72: 286-292.
9. Artini PG, Fasciani A, Monti M, Luisi S, D'Ambrogio G, Genazzani AR (1998) Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program. Fertil Steril 70: 560-564.
10. Agrawal R, Tan SL, Wild S, Sladkevicius P, Engmann L, Payne N, Bekir J, Campbell S, Conway G, Jacobs H (1999) Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertil Steril 71: 287-293.
11. Ludwig M, Bauer O, Lopens A, Jelkmann W, Diedrich K (1998) Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome. Hum Reprod 13: 30-32.
12. Kobayashi H, Okada Y, Asahina T, Gotoh J, Terao T (1998) The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome. J Mol Endocrinol 20: 363-374.
13. Ujioka T, Matsuura K, Tanaka N, Okamura H (1998) Involvement of ovarian kinin-kallikrein system in the pathophysiology of ovarian hyperstimulation syndrome: studies in a rat model. Hum Reprod 13: 3009-3015.
14. Kawano T, Okamura H, Tajima C, Fukuma K, Katabuchi H (1988) Effect of RU486 on luteal function in the early pregnant rat. J Reprod Fertil 83: 279-285.
15. Tanaka N, Iwamasa J, Matsuura K, Okamura H (1993) Effects of progesterone and anti-progesterone RU486 on ovarian 3,8-hydroxysteroid dehydrogenase activity during ovulation in the gonadotropin-primed immature rat. J Reprod Fertil 97: 167-172.
16. Ujioka T, Matsuura K, Kawano T, Okamura H (1997) Role of progesterone in capillary permeability in hyperstimulated rats. Hum Reprod 12: 1629-1634.
17. Finnerty H, Kelleher K, Morris GE, Bean K, Merberg DM, Kriz R, Morris JC, Sookdeo H, Turner KJ, Wood CR (1993) Molecular cloning of murine FLT and FLT4. Oncogene 8: 2293-2298.
18. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
19. Seko Y, Seko Y, Fujikura H, Pang J, Tokoro T, Shimokawa H (1999) Induction of vascular endothelial growth factor after application of mechanical stress to retinal pigment epithelium of the rat in vitro. Invest Ophthalmol Vis Sci 40: 3287-3291.
20. Cullinan-Bove K, Koos RD (1993) Vascular endothelial growth factor/Vascular permeability factor expression in the rat uterus: rapid stimulation by oestrogen correlates with oestrogen-induced increases in uterine capillary permeability and growth. Endocrinology 133: 829-837.
21. Lindenbaum ES, Bar Sela P, Itzkovitz J, Beach D, Brandeis J (1980) Ovarian hyperstimulation in rats. Eur J Obstet Gynecol Reprod Biol 11: 57-1167.
22. Phillips HS, Hains J, Leung DW, Ferrara N (1990) Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology 127: 965-967.
23. Ravindranath N, Little-Ihrig L, Phillips HS, Ferrara N, Zeleznick AJ (1992) Vascular endothelial growth factor mRNA expression in the primate ovary. Endocrinology 13: 1254-1260.
24. Koos RD (1995) Increased expression of vascular endothelial growth/permeability factor in the rat ovary following an ovulatory gonadotropin stimulus: Potential roles in follicle rupture. Biol Reprod 52: 1426-1435.
25. Neulen J, Yan Z, Raczek S, Weindel K, Keck C, Weich HA, Marine D, Breckwoldt M (1995) Human chorionic Gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 80: 1967-1971.
26. Conn G, Bayne ML, Soderman DD, Kwok PW, Sullvan KA, Palisi TM, Hope DA, Thomas KA (1990) Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor, Proc Natl Acad Sci USA 87: 2628-2632.
27. Ferrara N (1999) Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77: 527-543.
28. Liu Y, Cox SR, Morita T, Kourembanas S (1995) Hypoxia regulates vascular endothelial growth factor expression in endothelial cells. Circ Res 77: 638-643.
29. Hyder SM, Nawaz Z, Chiappetta C, Stancel GM (2000) Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res 60: 3183-3190.
30. Hyder SM, Stancel GM, Chiappetta C, Murthy L, Boettger-Tong HL, Makela S (1996) Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen. Cancer Res 56: 3954-3960.
31. Meirow D, Schenker JG, Rosler A (1996) Ovarian hyperstimulation syndrome with low oestradiol in non-classical 17 alpha-hydroxylase, 17,20-lyase deficiency: what is the role of oestrogens? Hum Reprod 11: 2119-2121.
32. Hild-Petito S, Stouffer RL, Brenner RM (1988) Immunocytochemical localization of estradiol and progesterone receptors in the monkey ovary throughout the menstrual cycle. Endocrinology 123: 2896-2905.
33. Anasti JN, Kalantaridou SN, Kimzey LM, George M, Nelson LM (1998) Human follicle fluid vascular endothelial growth factor concentrations are correlated with luteinization in spontaneously developing follicles. Hum Reprod 3: 1144-1147.
34. Hyder SM, Murthy L Stancel GM (1998) Progestin regulation of vascular endothelial growth factor in human breast cancer cells. Cancer Res 58: 392-395.
35. Sone H, Okuda Y, Kawakami Y, Kondo S, Hanatani M, Matsuo K, Suzuki H, Yamashita K (1996) Progesterone induces vascular endothelial growth factor on retinal pigment epithelial cells in culture. Life Sci 59: 21-25.
36. Groyer A, LeBouc Y, Radanyi C, Renoir JM, Robel P, Baulieu EE (1985) Chick oviduct glucocorticosteroid receptor. Specific binding of the synthetic steroid RU 486 and immunological studies with antibodies to chick oviduct progesterone receptor. Eur J Biochem 149: 445-451.
37. Hazzard TM, Molskness TA, Chaffin CL, Stouffer RL (1999) Vascular endothelial growth factor and angiopoietin regulation by gonadotropin and steroids in macaque granulosa cells during the peri-ovulatory interval. Mol Hum Reprod 5: 1115-1121.
38. Gerdes D, Christ M, Haseroth K, Notzon A, Falkenstein E, Wehling M (2000) Nongenomic actions of steroids-from the laboratory to clinical implications. J Pediatr Endocrinol Metab 13: 853-878.
39. Telleria CM, Stocco CO, Stati AO, Deis RP (1999) Progesterone receptor is not required for progesterone action in the rat corpus luteum of pregnancy. Steroids 64: 760-766.
40. Lei ZM, Chengini N, Rao CV (1991) Quantitative cell composition of human and bovine corpora lutea from various reproductive states. Biol Reprod 44: 1148-1156.
41. Gaytan F, Morales C, Bellido C, Aguilar R, Millan Y, Martin De Las Mulas J, Sanchez-Criado JE (2000) Progesterone on an oestrogen background enhances prolactin-induced apoptosis in regressing corpora lutea in the cyclic rat: possible involvement of luteal endothelial cell progesterone receptors. J Endocrinol 165: 715-724.
42. Lee A, Christenson LK, Patton PE, Burry KA, Stouffer RL (1997) Vascular endothelial growth factor production by human luteinized granulosa cells in vitro. Hum Reprod 12: 2756-2761.
43. Monacci W, Merrill M, Oldfield E (1993) Expression of vascular endothelial growth factor in normal rat tissues. Am J Physiol 264: C995-C1002.
44. Brown LF, Berse B, Togazzi K, Manseau EJ, Van de Water L, Senger DR, Dvorak HF, Rosen S (1992) Vascular permeability factor mRNA and protein expression in human kidney. Kidney Intl 42: 1457-1461.
45. Taylor RN, Lebovic DI, Homung D, Mueller MD (2001) Endocrine and paracrine regulation of endometrial angiogenesis. Ann NY Acad Sci 943: 109-121.
46. Espey LL, Coons PJ (1976) Factors which influence ovulatory regradation of rabbit ovarian follicles. Biol Reprod 14: 233-245.
47. Tanaka N, Espey LL, Okamura H (1989a) Increase in ovarian 15-hydroxyeicosatetraenoic acid during ovulation in the gonadotropin-primed immature rat. Endocrinology 125: 1373-1377.
48. Tanaka N, Espey LL, Okamura H (1989b) Increase in ovarian blood volume during ovulation in the gonadotropin-primed immature rat. Biol Reprod 40: 762-768.